<DOC>
	<DOCNO>NCT00301548</DOCNO>
	<brief_summary>The role early timing adjuvant chemotherapy postulate particularly important patient endocrine non-responsive disease . The role cytotoxicity period breast surgery immediately ( perioperative chemotherapy ) remain unknown . We investigate randomized trial role perioperative chemotherapy patient treat preoperative chemotherapy locally advance breast cancer compare preoperative chemotherapy without additional cytotoxic therapy immediately definitive surgery . Patients T2-3 N0-2 M0 breast cancer , estrogen receptor ( ER ) progesterone receptor ( PgR ) express less 20 % tumor cell , absence progesterone receptor , receive 6 course primary systemic therapy epirubicin 25 mg/m2 intravenously ( i.v . ) day 1 2 , cisplatin 60 mg/m2 i.v . day 1 , 5-fluorouracil 200 mg/m2 i.v . daily continuous infusion ( ECF ) . Patients achieve partial complete remission randomize continue infusion fluorouracil 2 week surgery ( perioperative treatment arm ) stop fluorouracil infusion one week surgery , day 21 sixth cycle ( control arm ) .</brief_summary>
	<brief_title>Perioperative Chemotherapy After Primary Chemotherapy Locally Advanced Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Patients breast cancer histologically proven &gt; 2 cm , ER PgR &lt; 20 % Any ER PgR absent ( T2 , T3 N02 , M0 ) No treatment previous chemotherapy/hormonotherapy Performance status 02 ( ECOG scale , Appendix 2 ) Measurable evaluable lesion Age 1870 year No significant intercurrent illness diabetes , cardiovascular , renal neurologic impairment Absence psychiatric illness WBC &gt; 4,000/mm3 ; PLTS &gt; 100,000/mm3 AST , ALT , LDH , gammaGT &lt; 2.5 x upper limit normal bilirubin &lt; 3 mg/100 ml Informed consent obtain Pregnancy test ( fertile woman ) . An effective contraceptive method must utilize fertile woman . Baseline examination ( chest X ray , CT scan , ECG etc ) perform within one month prior initiation therapy Uncontrolled infection metabolite disease Distant metastases Active peripheric and/or central neurological disease Active cardiac disease define CHF ( NYHA IIIIV ) significant arrhytmias , bilateral bundle branch block recent ( less 3 month ) history myocardial infarction History second malignancy ( exception situ carcinoma uterine cervix basal squamous cell carcinoma skin )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>antineoplastic protocol</keyword>
	<keyword>neoadjuvant therapy</keyword>
	<keyword>perioperative chemotherapy</keyword>
	<keyword>fluorouracil</keyword>
</DOC>